|
Originally published In Press as doi:10.1074/jbc.M104365200 on January 17, 2002
J. Biol. Chem., Vol. 277, Issue 14, 12175-12181, April 5, 2002
The COOH Terminus of Arylamine N-Acetyltransferase
from Salmonella typhimurium Controls Enzymic Activity*
Adeel
Mushtaq ,
Mark
Payton, and
Edith
Sim
From the Department of Pharmacology, University of Oxford,
Mansfield Road, Oxford OX1 3QT, United Kingdom
Received for publication, May 14, 2001, and in revised form, December 18, 2001
 |
ABSTRACT |
Arylamine N-acetyltransferases (NATs)
are a homologous family of enzymes, which acetylate arylamines,
arylhydroxylamines, and arylhydrazines by acetyl transfer from
acetyl-coenzyme A (Ac-CoA) and are found in many organisms. NAT was
first identified as the enzyme responsible for the inactivation of the
anti-tubercular drug isoniazid in humans. The three-dimensional
structure of NAT from Salmonella typhimurium has been
resolved and shown to have three distinct domains and an active site
catalytic triad composed of
"Cys69-His107-Asp122," which is
typical of hydrolytic enzymes such as the cysteine proteases. The
crystal unit cell consists of a dimer of tetramers, with the C terminus
of individual monomers juxtaposed. To investigate the function of the
first two domains of full-length NAT from S. typhimurium
and to investigate the role of the C terminus of NAT, truncation
mutants were made with either the C-terminal undecapeptide or the
entire third domain (85 amino acids) missing. Unlike the full-length
NAT protein (281 amino acids), the truncation mutants of NAT from
S. typhimurium are toxic when overexpressed intracellularly in Escherichia coli. Full-length NAT hydrolyses Ac-CoA but
only in the presence of an arylamine substrate. Both truncation
mutants, however, hydrolyze Ac-CoA even in the absence of arylamine
substrate, illustrating that the C-terminal undecapeptide controls
hydrolysis of Ac-CoA by NAT from S. typhimurium.
 |
INTRODUCTION |
Arylamine N-acetyltransferases
(NATs,1 EC 2.3.1.5) vary in
size from 30 to 34 kDa and form a distinct protein family (1). These
enzymes are found in a range of species from prokaryotes to humans and
catalyze the acetylation of many arylamine and arylhydrazine compounds
by catalyzing the transfer of an acetyl group from acetyl-coenzyme A
(Ac-CoA) to the terminal amino group of the substrate. This activity
plays an important role in the metabolism of drugs and xenobiotics
(2-4). It has also been proposed that a possible endogenous role for
NATs in humans is in the acetylation of a folate catabolite,
p-aminobenzoyl glutamate (5, 6), but as yet no endogenous
substrate is known for NATs in prokaryotes, although NAT activity has
been identified in prokaryotes, including several Mycobacteria (7-11).
While the members of the NAT family may have a common function it is
also possible that individual NATs carry out different roles in the
various organisms in which they have been found. The existence of the
NAT homologue, rifamycin-amide synthase (12, 13), which is involved in
the cyclization of an arylamine precursor to form the antibiotic
rifamycin in Amycolatopsis mediterrani also indicates that
NATs may have differing roles in different organisms.
NAT from Salmonella typhimurium was first identified
from strains of the bacterium used in the Ames test for carcinogens
(14) and it was also subsequently shown to be involved in the
activation of hydroxyarylamine carcinogens by O-acetylation
(2, 15, 16). Previously, kinetic studies on NAT from pigeon livers
showed the necessity of a sulfhydryl group for activity (17-19). It
was also these studies that led to the first suggestion of a
"ping-pong" mechanism involving a thio-acetyl intermediate.
Recently, the structure of NAT from S. typhimurium (ST-281),
which consists of 281 amino acid residues, was determined (20). The
structure revealed a unique fold, which has three distinct domains
(Fig. 1). The first two domains (Fig. 1a) showed similarity to the structure of proteins in the "papain" family of cysteine proteases such as staphopain (21). The structure of NAT illustrated the
presence of a
"Cys69-His107-Asp122" catalytic
triad, also found in the cysteine proteases (22). The three amino acid
residues of the catalytic triad are found in the first two domains of
NAT from S. typhimurium (Fig. 1a) and are
conserved in all members of the NAT family (20). This structural
similarity of NAT to the cysteine proteases suggested that NATs and the
cysteine proteases might have evolved from a common ancestor. The
structure of the unit cell of crystalline NAT from S. typhimurium is a pair of tetramers with each tetramer consisting
of a pair of dimers. The C termini (~residues 270 and beyond) of the
monomers in the individual dimers (Fig. 1a) are not visible
in the solved structure of NAT but must be in very close proximity from
the juxtaposition of the monomers in the unit cell (Fig. 1b)
(23).
We have investigated the function of the first two domains of
full-length NAT from S. typhimurium, which corresponds to
196 amino acid residues, and the role of the C terminus of NAT, by making truncation mutants with either the C-terminal undecapeptide (AAFDTHPEAGK) or the entire third domain missing (Fig. 1). Here we
report that these truncation mutants of NAT from S. typhimurium are toxic when overexpressed intracellularly in
Escherichia coli. We also demonstrate that only the
truncation mutants hydrolyze Ac-CoA in the absence of substrate and
illustrate that the C-terminal undecapeptide is essential in modulating
hydrolysis of Ac-CoA by NAT from S. typhimurium.
 |
EXPERIMENTAL PROCEDURES |
Cloning--
Fragments of the gene encoding full-length S. typhimurium NAT were cloned following amplification of the regions
from the open reading frame of NAT in genomic DNA from S. typhimurium (Strain L2, from Jay Hinton, IMM, Oxford). The forward
primer 5'-AGTCACTCATATGACCTCTTTTTTACAT-3' and reverse
primers 5'-ATTTTGTAAGCGGCCGCTCACATTACCGCGGCCAGCTC-3' and
5'-ATTTTGTAAGCGGCCGCTCATTGCGGCCAGTGAGCCGA-3' were used to amplify 589- and 811-bp fragments, respectively, which encode for
the first 196 amino acids (st-196) and 270 amino acids
(st-270) of full-length S. typhimurium NAT
(st-281). The 589- and 811-bp fragments were ligated into
the vector pGEMT (Promega) and transformed into E. coli
strain JM109 (Promega). The inserts were then subcloned into the
expression vector pET 28b(+) (Novagen Inc., Madison, WI), immediately
after the region encoding the hexa-histidine tag, using the
NotI and NdeI restriction sites (shown in bold) at the 5' and 3' ends, respectively. The plasmids, now with open reading frames corresponding to nst-196 and
nst-270, were then transfected into E. coli
strain BL21(DE3)pLysS (Promega). The nst-196,nst-270
fragments and the open reading frame of S. typhimurium NAT,
inclusive of a N-terminal hexa-histidine tag (nst-281) were further subcloned from pET28b(+), into the vector pBAD/gIII (24) (Invitrogen Inc., Groningen, Holland) using the NcoI and
XhoI sites, followed by transformation of the pBAD/gIII
vectors into E. coli strain TOP 10 (Invitrogen), for
propagation and expression. The sequences of the open reading frames of
the final constructs were confirmed.
Expression of nst-281, nst-270, and nst-196 Using
pET28b(+)--
Cultures (1 liter of LB containing chloramphenicol (34 µg/ml) and kanamycin (30 µg/ml)) of BL21(DE3)pLysS cells containing one of the pET28b(+) constructs (encoding NST-281, NST-270, or NST-196)
were grown (A600 of 0.6) at 27 °C (with 1 M sorbitol (10 h)) or at 37 °C (2.5 h) and then induced
with either 0.1 or 1 mM
isopropyl- -D-thiogalactopyranoside (IPTG) with 2.5 mM betaine added for cultures at 27 °C. Cultures
(A600 of 1 1.2) were harvested (7,000 × g, 4 °C, 10 min) and the pellets were each resuspended in
40 ml of lysis buffer (10 mM Tris-HCl, 1 mM
EDTA at pH 8.0 containing 10 mM CaCl2, 0.5 mg/ml lysozyme, 0.1 mg/ml DNase I, and 1 mM Pefabloc SC
(Pentapharm Ltd., Herts, UK)) and kept on ice for 30 min followed by 3 freeze-thaw cycles between liquid nitrogen and 42 °C. After
incubation (37 °C, 30 min) and centrifugation (15,000 × g, 4 °C, 15 min), the soluble fraction was collected and
the pellet was resuspended in the same volume of lysis buffer containing Tween 20 (1% (v/v)).
Testing for the Stability of the pET28b(+) Plasmid in E. coli--
Cultures of BL21(DE3)pLysS cells containing each of the
pET28b(+) constructs (encoding nst-281, nst-270,
or nst-196) were grown (A600 of 1) in
LB (chloramphenicol (34 µg/ml) and kanamycin (30 µg/ml)) followed
by dilution between 105 and 2 × 106-fold
before plating 1 ml on LB agar plates, containing 34 µg/ml chloramphenicol with or without kanamycin (30 µg/ml) and/or IPTG (1 or 0.1 mM) (25, 26). After 12 h at 37 °C the number
of growing colonies was counted.
Expression of nst-281, nst-270, and nst-196 Using
pBAD/gIII--
Cultures (1 liter of LB containing 50 µg/ml
ampicillin) of the E. coli strain TOP 10 containing one of
the pBAD/gIII constructs (nst-281, nst-270 or
nst-196) were grown at 37 °C, with shaking, to an
A600 of ~0.5 (2-3 h) and then induced (4 h)
with either 0.002% (w/v) L-arabinose (NST-281) or 0.2%
(w/v) L-arabinose (NST-270 and NST-196). Soluble fractions
were collected as described above. Where indicated, cells were
osmotically shocked with a 20% sucrose solution (24), and the
periplasmic fraction was removed by 3 cycles of centrifugation
(15,000 × g, 15 min) and washing (10 mM
Tris-HCl, 2.5 mM EDTA, pH 8.0). The remaining spheroplasts were then lysed, with lysis buffer as for the whole cells, and the
soluble fraction, corresponding to the cytoplasm, was collected following centrifugation (15,000 × g, 4 °C, 15 min).
Purification of NST-281, NST-270, or NST-196--
Recombinant
proteins and a mock expression control (empty pBAD/gIII vector) were
purified using Ni-NTA affinity chromatography (20, 27).
Protein concentrations of soluble fractions were determined by
measuring the absorbance at 280 nm or by using the Bradford assay (28).
NAT protein in insoluble fractions was quantitated following Western
blotting by comparison with known amounts of soluble pure NST-281.
Protein samples were denatured, reduced, and alkylated for 12%
SDS-PAGE (29). Gels were stained with Coomassie Blue (30) or probed for
NAT by Western blotting using a rabbit polyclonal antiserum against
pure ST-281 (11).
Enzymic Activities--
Enzymic activities were determined (17,
18, 27) using soluble fractions of freshly prepared bacterial cell
lysates, unless otherwise stated. All Michaelis constants,
Km, and maximum rates,
Vmax, were calculated using nonlinear
optimization (max iterations = 200) (31-33) from activities
measured in duplicate at a minimum of five substrate concentrations.
Three different enzymic activities were determined. (A)
Arylamine N-acetyl transfer activity was measured using
acetyl-CoA and 4-aminoveratrole (4AV), p-anisidine (ANS), or
isoniazid (INH). Reactions, containing up to 2 mM acetyl
donor or acceptor, were carried out in a total volume of 200 µl (20 mM Tris-HCl, 1 mM EDTA, and 1 mM
dithiothreitol, pH 7.5) at 37 °C and stopped by addition of an equal
volume of 20% (w/v) trichloroacetic acid (4 °C). The loss of
arylamine substrate was determined spectrophotometrically (27, 34) or
by high performance liquid chromatography (35). (B) The
enzymatic hydrolysis of Ac-CoA to CoA was determined using dithiobis(2-nitrobenzoic acid). Reactions were carried out as in A
except without dithiothreitol. The quantity of CoA generated was
determined by measuring the absorbance, at 410 nm, of the CoA-dithiobis(2-nitrobenzoic acid) conjugate as previously described (17). (C) Hydrolysis of p-nitrophenyl acetate
(PNPA) was determined by the rate of formation of
p-nitrophenol at 410 nm. The enzyme solution (final volume 1 ml) contained between 50 pg and 1 µg of pure protein in 20 mM Tris-HCl and 1 mM EDTA at pH 7.5 with the
addition of 2 mM INH as required. PNPA (final concentration up to 4 mM) was then added to the enzyme solution
(pre-heated to 37 °C) to start the reaction. The final concentration
of acetonitrile (used to dissolve PNPA) stock was less than 0.1% (v/v)
and had no effect on enzymic activity as determined using methods A and B.
Simulated "in Silico" Docking of Substrates--
All
non-polar hydrogen and terminal oxygen atoms were attached and
Gasteiger charges were assigned to the three-dimensional protein
structure of NAT from S. typhimurium (PDB accession number 1E2T) using the program SYBYL 6.5 (36). Three-dimensional structures of substrates, in MOL2 format, were created using SYBYL 6.5 and rotatable bonds and fixed rings were assigned using the program
AUTOTORS (37).
The substrate structures were then annealed to the protein structure
in silico using the AUTODOCK suite of programs (38). The lowest energy docking solutions were then viewed and analyzed using
SPDBV (39).
 |
RESULTS |
Expression of nst-281, nst-270, and nst-196 in the Cytosol of E. coli Using pET 28b(+)--
NST-270 and NST-196, which correspond to
NAT from S. typhimurium containing an N-terminal
hexa-histidine tag with either the C-terminal 11 amino acids or entire
third domain missing, respectively (Fig.
1), were produced as recombinant proteins
in E. coli. NST-270 and NST-196 were found in inclusion
bodies although the level of recombinant protein was very low (<100
µg/l of culture). In contrast, NST-281, which corresponds to the
full-length NAT from S. typhimurium containing an N-terminal
hexa-histidine tag, is soluble and recovered in high yield (~2
mg/liter of culture). When higher concentrations of IPTG (up to 1 mM) were used the level of expression of NST-270 and
NST-196 was greater, but still the amount of soluble protein produced,
was too low to be detected by Western blotting. No improvement in
solubility of NST-270 and NST-196 was obtained when cultures were grown
slowly (27 °C), a procedure which had previously proved successful
in generating soluble recombinant proteins (10).

View larger version (37K):
[in this window]
[in a new window]
|
Fig. 1.
The three-dimensional crystal structure of
NAT from S. typhimurium. a,
cartoon topology of the structure of a monomer of NAT from S. typhimurium (ST-281), in three distinct domains. Standard
nomenclature is used for the structural annotation and the amino acid
sequence is given below the structure in single
letter format. The protein sequence of the first two domains of
ST-281 is colored black with the sequence of the third
domain being colored green followed by the final C-terminal
undecapeptide, which is colored magenta. Residues in the
sequence with triangles above them indicate amino acid
residues of the "catalytic triad." The PDB accession number of
ST-281 is 1E2T and the structural topology was created using
"PDBsum" (50). b, a three-dimensional representation of
the structure of a dimer of NAT from S. typhimurium
(ST-281). The unit cell consists of a dimer of tetramers, with each
tetramer being composed of a pair of dimers. Each secondary structure
element is colored successively from the N terminus to the C terminus
for each individual monomer (blue through to
green for monomer B and then green through to
red for monomer A).
|
|
Toxicity of NST-270 and NST-196 Proteins in the Cytosol of E. coli--
To determine whether the low level of expression of the
truncated proteins was due to toxicity, plasmid stability tests were carried out (25). Colonies of BL21(DE3)pLysS, containing the pET28b(+)
vector with inserts encoding NST-270 or NST-196 were grown on LB agar
plates with or without kanamycin/IPTG combinations to determine the
number of colonies retaining the pET28b(+) plasmid with the different
inserts (26, 40, 41). The ratio of the number of colonies growing on
plates containing IPTG to plates containing both IPTG and kanamycin was
used to determine the percentage of colonies that had lost their
plasmid. Of the colonies that contained plasmids with the inserts
encoding for NST-270 and NST-196, 36 and 43%, respectively, lost their
plasmid in the presence of either 1 or 0.1 mM IPTG. For
comparison, the same experiment with NST-281 showed that in the
presence of 1 or 0.1 mM IPTG, only 10 or 4% of colonies,
respectively, had lost the plasmid with the nst-281 insert.
Expression of nst-281, nst-270, and nst-196 Using
pBAD/gIII--
Expression in the pBAD/gIII system leads to transport
of recombinant protein, prior to folding, from the cytoplasm to the periplasm by means of the gIII signal peptide, which is cleaved once
the protein reaches the periplasm (24, 42). However, for NST-270,
~50% of recombinant protein was found in the cytoplasm with
the gIII signal still attached, as determined on the basis of molecular
weight using Western blotting (Fig.
2

View larger version (22K):
[in this window]
[in a new window]
|
Recombinant NST-281, NST-270, and NST-196 in
the periplasm of E. coli (TOP 10) expressed from the
pBAD/gIII vector. a, SDS-12% PAGE analysis followed by
Coomassie Blue staining of whole cell lysates of the (15 µg of total
protein/lane) NST-281, NST-270, and NST-196 recombinant proteins, as
indicated, expressed using the pBAD/gIII vector. Whole cell lysate from
cells transfected with empty vector alone are also shown for
comparison. The same number of cells prior to lysis is loaded in each
lane. Molecular weight marker was loaded in the far left
lane. b, SDS-12% PAGE followed by Western blot
analysis of whole cell lysates. Individual lanes were loaded with the
whole cell lysate, pellet, or supernatant (containing both cytosol and
periplasm) fractions after expression of nst-280,
nst-270, or nst-196 as indicated. Approximately 1 µg of total protein was loaded into each lane. The lower
gel shows the pellet, supernatant (cytoplasm and periplasm), and
separated cytosolic fraction for NST-270 after removal of the periplasm
by osmotic shock, as described under "Experimental Procedures."
c and d, effect on production of soluble
recombinant proteins by varying the concentration of arabinose used for
induction. SDS-12% PAGE followed by Western blot analysis of the
soluble fractions of E. coli cell lysates after expression
of nst-281, nst-270, and nst-196 as indicated.
Expression of nst-281 and nst-270 was induced with different
amounts of arabinose (mg/liter) as shown below individual lanes.
Approximately 2 µg of total protein was loaded into each lane.
|
|
b). Minor contamination from
protein in the pellet could not be avoided when separating cytoplasmic
and periplasmic fractions.
Expression of nst-270 and nst-196, using this
system, resulted in much higher levels of expression than using the pET
system (Fig. 2a). The quantity of soluble truncated proteins
recovered was, however, much less than for NST-281 (1 mg/liter culture) when expressed using the pBAD/gIII system under similar conditions (Fig. 2b). All three recombinant proteins could nevertheless
be affinity purified from the soluble fraction of cell lysates.
Typically the N-terminal hexa-histidine-tagged proteins were eluted
with 50 mM imidazole yielding pure protein. Unlike NST-281,
the NST-196 and NST-270 proteins lost a large proportion of enzymic
activity during purification and were observed to precipitate rapidly
in high salt (300 mM), which is required for purification.
The enzymic activity of NST-270 and NST-196 in lysates was unstable and
could not be detected after 3 days at 4 °C. Therefore lysates were
used for activity assays within hours of preparation. These
observations were in contrast to those for NST-281, which was stable,
both when stored as lysate and during purification following expression using the pBAD/gIII system. During the purification of NST-270, the
higher molecular weight protein corresponding to NST-270 with the
uncleaved gIII signal peptide (~32,000) (Fig. 2b)
eluted at a different concentration of imidazole (250 mM)
to NST-270. This protein (NST-270 with the gIII signal sequence
attached) was enzymatically inactive.
Enzymic Analysis of Recombinant NAT Proteins--
All proteins
were assessed for N-acetyltransferase, Ac-CoA hydrolysis,
and PNPA hydrolysis activities as shown in Tables
I and II.
PNPA resembles an acetylated arylamine (Fig.
3).
View this table:
[in this window]
[in a new window]
|
Table I
Kinetic parameters for acetylation of arylamines
Kinetic parameters for the transfer of the acetyl group of Ac-CoA to
arylamine substrates are given. No acetyl transfer activity was
detected for the NST-196 protein using the substrates ANS, 4-AV, or
INH. Maximum velocity values are given in picomoles per minute per mg
of total soluble protein.
|
|
View this table:
[in this window]
[in a new window]
|
Table II
Effect of INH on the kinetic parameters for hydrolysis of Ac-CoA and
PNPA
Kinetic parameters for the enzymic hydrolysis of Ac-CoA and PNPA were
determined in the presence or absence of isoniazid (INH). Maximum
velocity values are given in picomoles per minute per mg of total
soluble protein except with PNPA where picomoles per minute per mg of
pure protein is used.
|
|

View larger version (41K):
[in this window]
[in a new window]
|
Fig. 3.
Simulated docking of substrates into the
structure NAT from S. typhimurium (ST-281).
a, the structures of the arylamine substrates, ANS and 4AV,
are shown along with the structure of the arylhydrazine substrate INH
and acetyl donor PNPA. The acetylated product acetyl-anisidine
(Ac-ANS) is also shown. The docking energies at the and
sites, as shown below the respective structures, are
given in kJ/mol. b, representation of the docking solutions
of ANS into binding site and PNPA into binding site of the
structure ST-281 as determined by simulated docking using the AUTODOCK
suite of programs (38). The protein structure of ST-281 is shown in
ribbon form with the residues of the catalytic triad also
indicated.
|
|
Arylamine N-acetyltransferase activity was observed only for
the NST-281 and NST-270 proteins. However, the Km
values for both proteins, with Ac-CoA, were too low (less than 20 µM) to be determined accurately, using the high
performance liquid chromatography method employed (35). Enzymatic
cleavage of Ac-CoA was observed with all three recombinant proteins in
the presence of 2 mM INH. When INH was not present, only
NST-270 and NST-196 hydrolyzed Ac-CoA as shown in Table II. The
hydrolysis of the acetyl donor PNPA, also only occurs with NST-281 in
the presence of INH. However, there are distinct differences in the
pattern of hydrolysis of both Ac-CoA and PNPA (Table II), by the
full-length and truncated NATs. The Michaelis constant obtained
for NST-281 expressed using the pBAD/gIII system was similar to that
obtained for NST-281 using the pET system in previous studies (27),
indicating that expression in the pBAD/gIII system has not adversely
affected the kinetic values.
Simulated Docking of Substrates--
The structures of 4AV, ANS,
INH, PNPA, and the acetylated forms of INH (Ac-INH) and ANS (Ac-ANS)
(Fig. 3a) were docked into the structure of NAT from
S. typhimurium and the lowest energy binding sites were
determined in each case. The sites described are an order of magnitude
lower in energy than the next best solutions.
The docking, of PNPA, revealed a preferential binding pocket (site )
for the benzene ring. The aromatic ring of PNPA appeared to interact
with Phe125, which is conserved in all prokaryotic NATs, by
a " - ring stacking" interaction with a docking energy of
21.1 kJ/mol ( 5.05 kcal/mol). The binding site was almost
identical in position to that for 4-bromoacetanilide (an irreversible
inhibitor covalently bound to the Cys69 residue) as
determined from the crystal structure of NAT from S. typhimurium with the inhibitor bound (20) (Fig.
3b).
The second series of docking studies were with substrates 4AV, ANS, and
INH. These compounds bind similarly to PNPA in site . Additionally,
these substrates, but not PNPA, were also bound at a second site ( )
(Fig. 3b). The interaction of the substrates at the second
site appeared to be with residues Ile36, Pro37,
and Phe38. These residues have previously been suggested to
contribute to Ac-CoA binding (11). The docking energy for 4AV, ANS, and INH was lower at site than at site (Fig. 3), indicating that 4AV, ANS, and INH bind at site in preference to site . It would be highly unlikely for acetyl transfer to occur at site because of
the 9.1-Å distance between the terminal nitrogen of a substrate bound at site and the sulfydryl of Cys69 (Fig.
3b). However, any substrate subsequently bound in the higher energy site , would have its terminal nitrogen (or oxygen for PNPA)
close enough to the active site Cys69 (3.0 Å) to allow
transfer of an acetyl group to and from the sulfhydryl group. No
significant binding sites were identified for the acetylated
substrates, Ac-INH and Ac-4AV.
 |
DISCUSSION |
When the truncated versions of NST-281 (NST-270 and NST-196) are
generated as recombinant proteins using the pET28b(+) system there is
very little protein produced compared with the production of NST-281.
The pET28b(+) plasmids encoding for nst-270 and
nst-196 are approximately four times more
unstable, in E. coli, than the plasmid encoding
for nst-281, suggesting that the NST-270 and NST-196
proteins are much more toxic than NST-281. This serves to explain why
so little recombinant NST-270 and NST-196 is produced (26). The minimal
toxicity of the NST-281 protein can be attributed to the large quantity
of soluble recombinant protein being produced disrupting usual cell
function (41). The toxicity of the truncation mutants is likely to be
due to an enzymic activity, rather than to accumulation of protein, as
very little NST-270 or NST-196 protein was produced. An analogous
situation has been observed with zymogens (such as trypsinogen), which
are only toxic when expressed in bacteria, if the inactivating peptide
at the N terminus is missing (43).
When the nst-196, nst-270, and nst-281 proteins were expressed
under conditions in which the recombinant proteins were excreted into
the periplasmic space (24, 42, 44), much higher levels of expression
for soluble NST-270 and NST-196 proteins (Fig. 2) were observed
relative to expression using the pET system. The quantity of soluble
NST-270 and NST-196 proteins produced in the periplasmic space was low
relative to the production of soluble NST-281 (Fig. 2, c and
d). It thus appears that the folded structure of NST-281 is
more stable than the structures of NST-270 and NST-196 and suggests
that the C-terminal region is essential for the stability of the
complete NST-281 fold. However, the enzymic activity of the NST-270 and
NST-196 proteins indicated clearly that low levels of correctly folded
proteins were present. Soluble, but inactive, NST-270 (with the gIII
signal still attached) was found in the cytosol and is unlikely to be
folded correctly since one of the features of the gIII transport system
is that folding of recombinant proteins is only completed after
transport to the periplasm (24, 42).
The acetyltransferase and hydrolytic activities of the truncated
versions of S. typhimurium NAT were different from those of
the full-length protein. The NST-281 and NST-270 proteins catalyzed the
acetyl transfer from Ac-CoA to 4AV, ANS, or INH whereas NST-196, which
completely lacks the third domain, showed no such activity. The lack of
acetyltransferase activity for NST-196 confirms that the third domain
of NST-281 is essential for the acetylation step (19). This has been
shown previously for human NAT1 (45) and suggests a common domain
structure for both NST-281 and human NAT1. The similarity of the
Km values of NST-270, for the acetylation of the
arylamines 4AV and ANS (200 µM), indicates that the
relative affinity for these two arylamine substrates has been abolished
in the shorter form of the protein. The Km values,
with NST-270, for both substrates (4AV and ANS) were lower than those
for NST-281 suggesting that the apparent affinity of NST-270 for the
arylamine substrates is greater than the apparent affinity of NST-281
for the same substrates. In contrast, the Km value
of NST-270 for Ac-CoA is over 8-fold greater than that of NST-281
(Tables I and II). The apparent affinity for Ac-CoA is much reduced on
removal of the C terminus of NST-281. This suggests that the C-terminal
undecapeptide plays an important role in substrate and Ac-CoA binding,
possibly by occluding access to the active site of the opposing NST-281
monomer if a dimer exists in solution (Fig. 1). The dependence of the
Km values, for the hydrolysis of Ac-CoA by NST-270
and NST-196, on the presence of INH (Table I) indicates that binding of
Ac-CoA also requires the presence of INH.
Only NST-270 and NST-196 hydrolyze Ac-CoA when there is no INH present,
which serves to explain the higher toxicity of these recombinant
proteins in the cytosol of E. coli. Intracellular concentrations of Ac-CoA have been measured to be of the order of 1 mM in E. coli (46, 47) and at this concentration
of Ac-CoA it would be expected that the truncated proteins, NST-270 and NST-196, would compete effectively with other endogenous
Ac-CoA-dependent enzymes, which are present in the cytosol
of E. coli. The recombinant NST-281 protein, in contrast,
would not compete in the absence of arylamine substrate. The control of
hydrolysis of Ac-CoA is therefore likely to be an important function of
the C terminus of NST-281, although it is still unknown how the
hydrolysis of Ac-CoA, in the absence of arylamine substrate, is
prevented in NST-281.
The simulated docking of 4AV, ANS, and INH to NAT from S. typhimurium revealed two binding sites ( and ) for the
aromatic substrates (Fig. 3b). In contrast, docking of PNPA
showed it was bound only at one site corresponding to the
substrate-binding site . The lack of good binding of the acetylated
substrates (AC-INH, Ac-4AV) also suggests that, once acetylated, the
substrates do not remain bound to the protein. Site is in close
proximity (~5 Å) to the putative "P-loop" which has been
considered as a possible binding region for the phosphate groups of
Ac-CoA in NAT from S. typhimurium (20) suggesting that site
, rather than site , may be involved in Ac-CoA binding.
The mode of interaction between NST-281 and Ac-CoA is unclear, although
a very strong "ring stacking" interaction between an aromatic
moiety and the adenosine ring of Ac-CoA has previously been
demonstrated in solution (48, 49). It is thus possible that the
arylamine substrate initially binds in site to form a new
Ac-CoA-binding site in which the aromatic ring of the substrate can
"ring stack" with the adenosine ring in Ac-CoA. This would serve to
explain the lack of hydrolysis in the absence of INH for NST-281 and
would also explain the lower Km values for the
hydrolysis of Ac-CoA by NST-270 and NST-196 in the presence of INH,
although it is clear that the C-terminal undecapeptide must also play a
role in regulation of the binding of Ac-CoA.
It is therefore proposed that the NAT protein must initially bind
arylamine substrate (at site ) to initiate a conformational change, which allows the subsequent binding of Ac-CoA and the acetylation of the active site cysteine. Subsequent acetyl transfer can
then occur from the acetylated-protein intermediate to the substrate
(now bound at site ).
In conclusion, the C terminus of NAT from S. typhimurium
regulates the binding of Ac-CoA in the absence of substrate such that
there is control over hydrolysis of Ac-CoA. It is also possible that
the first two domains of NAT from S. typhimurium and the corresponding domains of the cysteine proteases have evolved from a
common ancestor with the third domain of NAT from S. typhimurium acting to regulate the hydrolytic function of the NAT protein.
 |
ACKNOWLEDGEMENTS |
We thank Drs. Katalin Pinter, Martin Noble,
John Sinclair, Dawn O'Reilly, and Grant Churchill for helpful
discussion and advice. We also thank James Sandy for technical assistance.
 |
FOOTNOTES |
*
This work was supported by the Wellcome Trust and a Medical
Research Council (United Kingdom) studentship (to A. M.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed: Dept. of Pharmacology,
University of Oxford, Oxford, OX1 3QT, United Kingdom. Tel.:
44-1865-271595; Fax: 44-1865-271853; E-mail:
adeel.mushtaq@pharm.ox.ac.uk.
Published, JBC Papers in Press, January 17, 2002, DOI 10.1074/jbc.M104365200
 |
ABBREVIATIONS |
The abbreviations used are:
NAT, arylamine
N-acetyltransferase;
ANS, p-anisidine(4-methoxyaniline);
4AV, 4-aminoveratrole
(3,4-dimethoxy aniline);
INH, isoniazid;
PNPA, 4-nitrophenyl
acetate;
ST-281, full-length (281 residues) NAT protein from S. typhimurium;
NST-281, recombinant ST-281 with an N-terminal
hexa-histidine tag;
NST-270, recombinant protein corresponds to
N-terminal 270 amino acid residues of ST-281 with an N-terminal
hexa-histidine tag;
NST-196, recombinant protein corresponds to
N-terminal 196 amino acid residues of ST-281 with an N-terminal
hexa-histidine tag;
IPTG, isopropyl- -D-thiogalactopyranoside;
Ac-CoA, acetyl-coenzyme A.
 |
REFERENCES |
| 1.
|
Upton, A.,
Johnson, N.,
Sandy, J.,
and Sim, E.
(2001)
Trends Pharmacol. Sci.
22,
140-146
|
| 2.
| Hein, D. W., Rustan, T. D., Doll, M. A., Bucher, K. D., Ferguson, R. J., Feng, Y., Furman, E. J., and Gray, K. (1992) Toxicol. Lett. 123-130
|
| 3.
|
Hein, D. W.,
Rustan, T. D.,
Ferguson, R. J.,
Doll, M. A.,
and Gray, K.
(1994)
Arch. Toxicol.
68,
129-133
|
| 4.
|
King, C. M.,
Land, S. J.,
Jones, R. F.,
Debiec-Rychter, M.,
Lee, M. S.,
and Wang, C. Y.
(1997)
Mutat. Res.
12,
123-128
|
| 5.
|
Minchin, R. F.
(1995)
Biochem. J.
307,
1-3
|
| 6.
|
Upton, A.,
Smelt, V.,
Mushtaq, A.,
Aplin, R.,
Johnson, N.,
Mardon, H.,
and Sim, E.
(2000)
Biochim. Biophys. Acta
1524,
143-148
|
| 7.
|
Chung, J.,
Wang, H.,
Tsou, M.,
Hsieh, S., Lo, H.,
Yen, Y.,
Chang, S., Wu, L.,
Lee, J.,
and Hung, C.
(1997)
Toxicol. Lett.
91,
63-71
|
| 8.
|
Chung, F. C.,
and Chung, G. C.
(1998)
Curr. Microbiol.
3,
125-130
|
| 9.
|
Delomenie, C.,
Fouix, S.,
Longuemaux, S.,
Brahimi, N.,
Bizet, C.,
Picard, B.,
Denamur, E.,
and Dupret, J.-M.
(2001)
J. Bacteriol.
183,
3417-3427
|
| 10.
|
Payton, M.,
Auty, R.,
Delgoda, R.,
Everett, M.,
and Sim, E.
(1999)
J. Bacteriol.
181,
1343-1347
|
| 11.
|
Payton, M.,
Mushtaq, A., Yu, T. W., Wu, L. J.,
Sinclair, J.,
and Sim, E.
(2001)
Microbiology
147,
1137-1147
|
| 12.
|
Floss, H.,
and Yu, T.-W.
(1999)
Curr. Opin. Chem. Biol.
3,
592-597
|
| 13.
|
Yu, T.-W.,
Shen, Y.,
Doi-Katayama, Y.,
Tang, L.,
Park, C.,
Moore, B.,
Hutchinson, C.,
and Floss, H.
(1999)
Proc. Natl. Acad. Sci. U. S. A.
96,
9051-9056
|
| 14.
|
Watanabe, M.,
Nohmi, T.,
and Ishidate, M., Jr.
(1987)
Biochem. Biophys. Res. Commun.
147,
974-979
|
| 15.
|
Josephy, P. D.,
Evans, D. H.,
Parikh, A.,
and Guengerich, F. P.
(1998)
Chem. Res. Toxicol.
11,
70-74
|
| 16.
|
Dang, L. N.,
and McQueen, C. A.
(1999)
Toxicol. Appl. Pharmacol.
159,
77-82
|
| 17.
|
Riddle, B.,
and Jencks, W. P.
(1971)
J. Biol. Chem.
246,
3250-3258
|
| 18.
|
Jencks, W. P.,
Gresser, M.,
Valenzuela, M. S.,
and Huneeus, F. C.
(1972)
J. Biol. Chem.
247,
3756-3760
|
| 19.
|
Watanabe, M.,
Sofuni, T.,
and Nohmi, T.
(1992)
J. Biol. Chem.
267,
8429-8436
|
| 20.
|
Sinclair, J.,
Sandy, J.,
Delgoda, R.,
Sim, E.,
and Noble, M.
(2000)
Nat. Struct. Biol.
7,
560-564
|
| 21.
|
Graf, L.,
Hegyi, G.,
Liko, I.,
Hepp, J.,
Medzihradszky, K.,
Craik, C. S.,
and Rutter, W. J.
(1988)
Int. J. Pept. Protein Res.
32,
512-518
|
| 22.
|
Turk, D.,
Guncar, G.,
Podobnik, M.,
and Turk, B.
(1998)
Biol. Chem.
379,
137-147
|
| 23.
| Sandy, J., Mushtaq, A., Kawanamura, A., Sim, E., and Noble, M. (2002)
J. Mol. Biol., in press
|
| 24.
| Zinder, N. D., Model, P., and Boeke, J. D. (1986) U. S.
Patent 416922
|
| 25.
|
Mierendorf, R. C.,
Morris, B. B.,
Hammer, B.,
and Novy, R. E.
(1998)
Methods Mol. Med.
13,
257-292
|
| 26.
|
Pan, S.-h.,
and Malcolm, B. A.
(2000)
BioTechniques
29,
1234-1236; 1238
|
| 27.
|
Sinclair, J.,
Delgoda, R.,
Noble, M.,
Jarmin, S.,
Goh, N.,
and Sim, E.
(1998)
Protein Expr. Purif.
12,
371-380
|
| 28.
|
Thorne, C. J. R.
(1978)
Tech. Life Sci. Biochem. Sect. B
104,
1-18
|
| 29.
|
Sim, R. B.,
and Sim, E.
(1981)
Biochem. J.
193,
129-141
|
| 30.
|
Pagano, M.
(1999)
Anal. Chim. Acta
383,
119-125
|
| 31.
|
Lawson, C. L.,
and Hanson, R. T.
(1974)
Solving Least Squares Problems
, Prentice-Hall, Englewood
|
| 32.
|
Björk, Å.
(1967)
BIT (Tidskrift for Informations Behandling) Numerical Mathematics
7,
1-21
|
| 33.
|
Watanabe, T.,
and Natori, M.
(1989)
in
in Numerical Calculation Software, Trans. Japanese
(Oguni, T., ed)
, Maruzen, Tokyo
|
| 34.
|
Ward, A.,
Summers, M.,
and Sim, E.
(1995)
Biochem. Pharmacol.
49,
1759-1767
|
| 35.
|
Hutchings, A.,
Monie, R. D.,
Spragg, B.,
and Routledge, P. A.
(1983)
J. Chromatogr.
277,
385-390
|
| 36.
| www.tripos.com. (2000) TRIPOS (SYBYL), Version
6.5
|
| 37.
|
Morris, D.,
Goodsell, D.,
Huey, R.,
and Olson, A.
(1996)
J. Comput.-aided Mol. Des.
10,
293-304
|
| 38.
|
Morris, G.,
Goodsell, D.,
Halliday, R.,
Huey, R.,
Hart, W.,
Belew, R.,
and Olson, A.
(1998)
J. Comput. Chem.
19,
1639-1662
|
| 39.
|
Guex, N.,
and Peitsch, M. C.
(1997)
Electrophoresis
18,
2714-2723
|
| 40.
|
Hutchins, B.,
Bothones, N.,
and Peterson, W.
(1941)
J. Biol. Chem.
141,
521-528
|
| 41.
| Walker, J., and Miroux, B. (1998) United Kingdom PCT Patent
W09802559
|
| 42.
|
Davis, N. G.,
Boeke, J. D.,
and Model, P.
(1985)
J. Mol. Biol.
181,
111-121
|
| 43.
|
Vasquez, J. R.,
Evnin, L. B.,
Higaki, J. N.,
and Craik, C. S.
(1989)
J. Cell. Biochem.
39,
265-276
|
| 44.
|
Dalbey, R. E.,
and Wickner, W.
(1985)
J. Biol. Chem.
260,
15925-15931
|
| 45.
|
Sinclair, J.,
and Sim, E.
(1997)
Biochem. Pharmacol.
53,
11-16
|
| 46.
|
Takamura, Y.,
and Nomura, G.
(1988)
J. Gen. Microbiol.
134,
2249-2253
|
| 47.
|
Pruess, B. M.,
and Wolfe, A. J.
(1994)
Mol. Microbiol.
12,
973-984
|
| 48.
|
Ueyama, M.,
Tori, K.,
Ikehara, M.,
and Kaneko, M.
(1974)
Nucleic Acids Res.
1,
823-834
|
| 49.
|
Mieyal, J. J.,
Webster, L. T., Jr.,
and Siddiqui, U. A.
(1974)
J. Biol. Chem.
249,
2633-2640
|
| 50.
|
Laskowski, R. A.,
Hutchison, E. G.,
Michie, A. D.,
Wallace, A. C.,
Jones, M. L.,
and Thornten, J. M.
(1997)
Trends Biochem. Sci.
22,
488-490
|
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
Y. Zang, M. A. Doll, S. Zhao, J. C. States, and D. W. Hein
Functional characterization of single-nucleotide polymorphisms and haplotypes of human N-acetyltransferase 2
Carcinogenesis,
August 1, 2007;
28(8):
1665 - 1671.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. M. Walraven, J. O. Trent, and D. W. Hein
Computational and Experimental Analyses of Mammalian Arylamine N-Acetyltransferase Structure and Function
Drug Metab. Dispos.,
June 1, 2007;
35(6):
1001 - 1007.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. M. Walraven, M. A. Doll, and D. W. Hein
Identification and Characterization of Functional Rat Arylamine N-Acetyltransferase 3: Comparisons with Rat Arylamine N-Acetyltransferases 1 and 2
J. Pharmacol. Exp. Ther.,
October 1, 2006;
319(1):
369 - 375.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. J. Butcher, A. Arulpragasam, and R. F. Minchin
Proteasomal Degradation of N-Acetyltransferase 1 Is Prevented by Acetylation of the Active Site Cysteine: A MECHANISM FOR THE SLOW ACETYLATOR PHENOTYPE AND SUBSTRATE-DEPENDENT DOWN-REGULATION
J. Biol. Chem.,
May 21, 2004;
279(21):
22131 - 22137.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Bhakta, G. S. Besra, A. M. Upton, T. Parish, C. Sholto-Douglas-Vernon, K. J.C. Gibson, S. Knutton, S. Gordon, R. P. daSilva, M. C. Anderton, et al.
Arylamine N-Acetyltransferase Is Required for Synthesis of Mycolic Acids and Complex Lipids in Mycobacterium bovis BCG and Represents a Novel Drug Target
J. Exp. Med.,
May 3, 2004;
199(9):
1191 - 1199.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Dairou, N. Atmane, F. Rodrigues-Lima, and J.-M. Dupret
Peroxynitrite Irreversibly Inactivates the Human Xenobioticmetabolizing Enzyme Arylamine N-Acetyltransferase 1 (NAT1) in Human Breast Cancer Cells: A CELLULAR AND MECHANISTIC STUDY
J. Biol. Chem.,
February 27, 2004;
279(9):
7708 - 7714.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. E. Summerscales and P. D. Josephy
Human Acetyl CoA:Arylamine N-Acetyltransferase Variants Generated by Random Mutagenesis
Mol. Pharmacol.,
January 1, 2004;
65(1):
220 - 226.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Atmane, J. Dairou, A. Paul, J.-M. Dupret, and F. Rodrigues-Lima
Redox Regulation of the Human Xenobiotic Metabolizing Enzyme Arylamine N-Acetyltransferase 1 (NAT1): REVERSIBLE INACTIVATION BY HYDROGEN PEROXIDE
J. Biol. Chem.,
September 12, 2003;
278(37):
35086 - 35092.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|